Michaela L. Vance

Michaela L. Vance

Auto-generated profile, based on publicly available information

Michaela L. Vance

Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2025 in NeuroImage
Verified
Journal Article
Open access
JPJessica Pinckard
Jessica Pinckard
SNSharon Negri
Sharon Negri
CHCade A Huston
Cade A Huston
MBMarisa A Bickel
Marisa A Bickel
MVMichaela L Vance
Michaela L Vance
SCShannon Conley
Shannon Conley
Aging is associated with impaired cerebrovascular function, including reduced functional hyperemia (FH), which contributes to cognitive decline and dementia. Unraveling the mechanisms responsible for FH decline during aging is crucial for developing interventions to promote healthy brain aging and mitigate cognitive impairment. Currently, laser speckle contrast imaging (LSCI) serves as the standard method for assessing FH in mouse models of cognitive dysfunction and aging. However, as a terminal procedure, long-term monitoring of changes in FH using LSCI is not possible. Functional ultrasound imaging (fUS) has improved spatial and temporal resolution compared to LSCI and is a promising alternative, but surgical manipulation of the mouse model is necessary to assess FH using fUS. Here, we validated fUS as a novel method for assessing FH and vascular density in mice using a chronological aging model and compared different surgical paradigms. Young and aged mice underwent consecutive imaging with fUS and LSCI following surgical placement of a cranial window. Mice were imaged either acutely or 14 days post window placement. Our findings revealed a robust correlation between the FH measurements obtained from fUS and LSCI in mice allowed to recover for 14 days post window-implantation, underscoring the reliability of fUS as a measurement tool. Similarly, the ability of fUS ultrasound localization microscopy (ULM) to detect age-related vascular rarefaction was improved by the 14-day recovery time after window implantation. This study not only highlights the potential of fUS in FH assessment but also suggests the importance of recovery time post-surgery for optimal cerebrovascular imaging results.

10 October 2025 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Open access
MVMichaela L. Vance
Michaela L. Vance
DNDorina Nagy
Dorina Nagy
EBEvelyn Brunner
Evelyn Brunner
VMVasileios Morkotinis
Vasileios Morkotinis
JBJadance L. Black
Jadance L. Black
SCShannon Conley
Shannon Conley
Age-related dysfunction of the central nervous system, including cognitive impairment and visual disorders, is a major concern for the aging population, affecting health span and quality of life. Age-related vascular dysfunction in the central nervous system includes an increase in blood-brain or blood-retina barrier permeability, an increase in vascular fragility, and impaired neurovascular coupling, contributing to cognitive impairment and vision loss. While these pathologies occur in the brain and eye with age, gaps remain in our understanding of the underlying cellular mechanisms. During the process of endothelial-to-mesenchymal transition (EndMT), endothelial cells lose their characteristic endothelial phenotypes, which are critical for vascular function, such as barrier integrity, and transition to a mesenchymal-like phenotype. EndMT is triggered by many age-related stimuli and is involved in the progression of many age-related diseases (eg, atherosclerosis, cardiovascular disease, etc). Here, we review what is known about the role of EndMT in vascular fragility in the aging brain and eye, explore the mechanistic links between endothelial cell transdifferentiation and age-associated vascular pathologies of the central nervous system, and identify potential therapeutic targets ripe for future exploration with the goal of preserving vascular function with aging by regulating EndMT. SIGNIFICANCE STATEMENT: Endothelial-to-mesenchymal transition is a key form of cellular plasticity that leads to disrupted barrier function and vascular disorders. Here, we evaluate what is known about this process in the brain, highlight potential targetable mechanisms to block it, and identify areas where further research is needed.